Recommendations for the diagnosis and treatment of rheumatic fever in China
10.3760/cma.j.cn112138-20221029-00802
- VernacularTitle:风湿热诊疗规范
- Author:
Jieruo GU
1
;
Zhiming LIN
;
Youlian WANG
;
Long LI
;
Pingting YANG
;
Yan ZHAO
Author Information
1. 中山大学附属第三医院风湿免疫科 广东省免疫病临床研究中心 国家皮肤与免疫疾病临床医学研究中心分中心，广州 510630
- Keywords:
Rheumatic fever;
Diagnosis;
Treatment;
Prognosis
- From:
Chinese Journal of Internal Medicine
2023;62(9):1052-1058
- CountryChina
- Language:Chinese
-
Abstract:
Rheumatic fever is an autoimmune disease characterized by recurring acute or chronic systemic connective tissue inflammation caused by group A streptococcal infection in the throat. Although rheumatic fever is common in China, there is a lack of standardized criteria for the diagnosis and treatment of this condition. Based on evidence and guidelines from China and other countries, the Chinese Rheumatology Association developed standardized criteria for the diagnosis and treatment of this disease in China. The aim was to standardize rheumatic fever diagnosis methods, treatment opportunities, and strategies for both short-and long-term treatment, so as to reduce irreversible damage and improve prognosis.
